Marksans Pharma’s arm gets marketing authorization for two products

17 Nov 2025 Evaluate

Marksans Pharma’s wholly owned subsidiary -- Relonchem in UK has received marketing authorization for its Mefenamic Acid 250 mg Film-Coated Tablets and Mefenamic Acid 500 mg Film-Coated Tablets from UK Medicines & Healthcare products Regulatory Agency (UK MHRA). 

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.

Marksans Pharma Share Price

173.10 0.15 (0.09%)
12-Mar-2026 12:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1827.20
Dr. Reddys Lab 1318.70
Cipla 1329.25
Zydus Lifesciences 921.25
Lupin 2340.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×